Lawsuit Filed Against Laidlaw & Co.
The White Law Group has filed a Lawsuit against Laidlaw & Co. Alleging Over-concentration in High-risk Investments.
The White Law Group has filed and submitted a FINRA claim on behalf of a Florida resident alleging claims for violation of common law fraud, breach of fiduciary duty, negligence, and negligent supervision against Laidlaw & Co.
The claim further alleges that Laidlaw & Co. unsuitably invested the client in the following high risk start-ups, private stock and restricted stock offerings, restricted Note offerings, private placement investments:
Aethlon Medical, Inc.
5G Investment LLC
Aspen Group Inc.
Brazahav Resources Inc.
Fusion Telecoms International, Inc.
Protea Biosciences Group Inc.
Aeolus Pharmaceuticals Inc.
Biosig Technologies Inc.
Contravir Pharmaceuticals Inc.
The claim seeks damages between $1,000,000 and $2,000,000.
It is alleged Laidlaw & Co. failed to properly supervise the broker of record, and failed to perform the necessary due diligence on these investments prior to recommending them to this particular investor. Further, the claim alleges that Laidlaw & Co. is liable for its role in a “pump and dump” scheme driven by an investor group led by Barry Honig which Laidlaw assisted and enabled to the tune of millions of dollars in profit at the expense of the investing public including Claimant.
Before recommending an investment, a broker-dealer has a fiduciary duty to adequately disclose the risks involved in the investment and to perform the necessary due diligence to determine whether the investment is suitable for the investor.
According to D. Daxton White, managing partner of The White Law Group, ” It is unfortunate, but we believe that many more investors have suffered devastating losses due to the broker-dealer’s failure to supervise and don’t realize they have recovery options.”
“Brokerage firms are required to supervise their advisors to ensure that they are complying with FINRA rules. If it can be determined that the broker violated FINRA rules and the employers failed to adequately supervise him, these firms can be held responsible for any resulting losses in a FINRA arbitration claim.”
FINRA Dispute Resolution is an arbitration venue for investors with claims against their brokerage firm or financial professional. It provides investors with an opportunity to attempt to recoup their investment losses without filing such claims in court.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information The White Law Group and the claim filed against Laidlaw & Co., please contact the firm at 1-888-637-5510 or visit https://www.whitesecuritieslaw.com.
[maxbutton id=”1″ ]Tags: 5G Investment LLC, 5G Investment LLC losses, Actinium Boston Therapeutics, Actinium Pharma losses, Aeolus Pharmaceuticals, Aeolus Pharmaceuticals Inc., Aethlon Medical Inc., Aethlon Medical Inc. losses, Alliqua Inc., Aspen Group Inc., Aspen Group Losses, BioSig Technologies Inc., Boston Therapeutics lawsuit, Brazahav Resources Inc., Contravir Pharmaceuticals Inc., Contravir Pharmaceuticals Inc. losses, Fusion Telecoms International Inc., Fusion Telecoms International losses, Laidlaw & Co. finra claim, Laidlaw & Co. lawsuit, Laidlaw & Co. penny stocks, Laidlaw & Co. pump & dump, Laidlaw & company, Laidlaw & company investigation, Laidlaw & Company lawsuit, Laidlaw & Company losses, Medovex Corp., Protea Biosciences Group Inc., Protea Biosciences Group Inc. losses, Relmada Therapeutics, Relmada Therapeutics Laidlaw, Relmada Therapeutics losses, Sevion Therapeutics, Spectrascience Inc., Spherix Inc. Last modified: April 26, 2019